Clovis Oncology to Present at the Credit Suisse Annual Healthcare Conference

  Clovis Oncology to Present at the Credit Suisse Annual Healthcare Conference

Credit Suisse Healthcare Conference 2013

Business Wire

BOULDER, Colo. -- November 5, 2013

Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Erle T. Mast, the
Company’s executive vice president and CFO, will present at the Credit Suisse
Annual Healthcare Conference on Tuesday, November 12, at 4:00pm MST. The
conference is being held at The Phoenician in Scottsdale, Arizona.

A live webcast of the corporate presentation at the conference will be
accessible through the investor relations section of the Company’s website at
www.clovisoncology.com. Following the live presentation, a replay of the
webcast will be available on the Company’s website for 30 days.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring,
developing and commercializing innovative anti-cancer agents in the U.S.,
Europe and additional international markets. Clovis Oncology targets
development programs at specific subsets of cancer populations, and
simultaneously develops diagnostic tools that direct a compound in development
to the population that is most likely to benefit from its use. Clovis Oncology
is headquartered in Boulder, Colorado, and has additional offices in San
Francisco, California and Cambridge, UK.

Contact:

Clovis Oncology, Inc.
Anna Sussman, 303-625-5022
asussman@clovisoncology.com
or
Breanna Burkart, 303-625-5023
bburkart@clovisoncology.com